ARCHIVES

Survival Benefit For Vinorelbine-Cisplatin In NSCLC Patient, Phase III Trial Finds

This article is from The Cancer Letter archive.

Vol. 28 No. 8 | August 26, 2005

Download PDF Visit The Full Archive

Related Articles

NCI Advisory Group, Other Cancer Meetings

July 25, 1986

FDA Simplifies Reporting Of Adverse Events

June 18, 1993

Combine Phase 1-2, Abolish DRG, Slash Indirect Costs, Garb Tells Congress

November 27, 1981

In Brief: James Cancer Hospial Recieves $20M Donation

January 22, 1999

CCOP Applications Total 110(At Least), Plus 25 from Research Bases; All 57 Survivors Try Again

November 21, 1986

New Agency To Evaluate PDQ; NCAB Approves NCI Payment Of Part

June 1, 1990